Compare GE Vernova Inc (GEV) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? GE Vernova Inc trades at $987.07 (market cap $266.16B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.19 (market cap $6.04B). The key difference: GE Vernova Inc is far larger — about 44.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and GE Vernova Inc pays a 0.2% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Vernova Inc for 36 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GEV | IOVA | |
|---|---|---|
Market Cap | $266.16B | $6.04B |
Volume | 2,324,165 | 14,805,993 |
Sector | Industrials | Health |
52-Week High | $1.17K | $14.82 |
52-Week Low | $547.96 | $1.81 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $255.83B | $5.97B |
Dividend Yield | 0.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $986.62, down 1.05% today but maintains strong analyst support with 22 buy ratings and a $1,270 consensus price target. The stock shows bullish technical momentum with support at $973 and resistance at $1,026. Recent Q1 2026 earnings beat expectations with EPS of $17.44 versus $1.95 expected, while Q2 2026 missed estimates. The company secured the first US construction permit for its BWRX-300 small modular reactor, strengthening its nuclear pipeline amid growing AI-driven power demand.
Outlook remains positive with projected revenue growth to $41.4B in 2026 and net profit margin expanding to 23.03%. Key risks include valuation concerns with P/E of 28.65 and EV/EBITDA of 85.22, plus execution challenges in scaling nuclear projects. The stock offers exposure to AI infrastructure growth but requires monitoring of margin expansion and backlog conversion.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
